If you need more lookups,
subscriptions start at $34 USD/month.
Melanie Ackerley Location
United Kingdom
Melanie Ackerley Work
2026 -now Quality Director and QP @
2023 -2026 Director of Quality @
2021 -2023 Global Head of Quality and Qualified Person @
2016 -2021 Head of Quality @
2014 -2015 Head of Quality @
2013 -2013 QC Manager @
2009 -2013 Microbiology Manager @
2005 -2009 Principal Consultant @ ABB Ltd
1998 -2005 Principal Consultant @ ICI Eutech
1997 -1998 Validation Manager @ Novartis Vaccines
1990 -1997 Head of Quality Assurance @ Novartis
1988 -1990 Quality Compliance Officer @ Evans Medical
1987 -1988 Senior Microbiologist @ Evans Medical
Melanie Ackerley Education
The Manchester Metropolitan University
Medical Microbiology (Medical Microbiology)
Melanie Ackerley Skills
Pharmaceutical Industry
FDA
Quality Auditing
21 CFR Part 11
GMP
Quality Assurance
Validation
Change Control
Sop
Aseptic Processing
Quality Control
Biotechnology
GLP
Microbiology
CAPA
LIMS
V&V
Laboratory
Business Analysis
Molecular Biology
Microsoft Office
Melanie Ackerley Summary
Melanie Ackerley, based in United Kingdom, is currently a Quality Director and QP at Rose BioSolutions. Melanie Ackerley brings experience from previous roles at Charles River Laboratories, Quay Pharma and Recipharm. Melanie Ackerley holds a Medical Microbiology in Medical Microbiology @ The Manchester Metropolitan University. With a robust skill set that includes Pharmaceutical Industry, FDA, Quality Auditing, 21 CFR Part 11, GMP and more. Melanie Ackerley has 2 emails on RocketReach.
Looking for a different Melanie Ackerley?
Find contact details for 700 million professionals.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.